E1 Eicosanoids Flashcards

1
Q

give examples of mediators

A

hormones, cytokines, nucleosides, nucleotides, basic amines, lipids/fatty acids, enzymes and peptides etc….

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Criteria for establishing a substance as a mediator are:

A
  • It is released from local cells in sufficient quantity to mediate biological activity on target cells within an appropriate time frame
  • Application of an authentic sample of the proposed mediator reproduces the biological effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe eicosanoids

  • storage (time)
  • signaling
A

Group of mediators that are generated from FA precursors (arachidonic acid)
Not stored ‘pre-formed’ in the cell: Degraded quickly so they cannot travel far in the body (within 30s-5mins)
can mediate paracrine and autocrine signaling but NOT endocrine signaling (as degraded)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the rate limiting step in eicosanoid synthesis

A

catalyst = phospholipase A2-mediated release of fatty acids (arachidonic acid) from phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what enzymes are involves in metabolisation of arachidonic acid

A

epoxygenase, cyclo-oxygenase (COX) and lipoxygenase (LOX) —> results in generation of a host of eicosanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does the eicosanoid produced depend on

A

cell type and isomerases/synthases enzymes present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what inhibits both COX1 & COX2 irreversibly

A

Aspirin - anti-inflammatory and anti-platelet agent via blocking platelet TXA2 synthesis via inhibition of COX1 (reduces the risk of thrombosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name the 5 different prostanoids receptors identified

A

All GPCRs

  • Prostaglandin D2(PGD2)receptors: DP1 and DP2
  • Prostaglandin E2receptors: EP1-EP4
  • Prostaglandin F receptor: FP
  • Prostaglandin I2 (prostacyclin) receptors: IP1 and IP2
  • Thromboxane receptor(TP): TPα (TXA2) and TPβ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe NSAIDs

  • what do they inhibit
  • what does that prevent
A

non-steroidal anti-inflammatory drugs - main COX inhibitors COX1 & COX2

  • inhibit prostaglandin and thromboxane synthesis
  • reduces inflammation
  • antithrombotic (low dose aspirin) and analgesic effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

patients lacking COX1 have what disorder

A

mild bleeding disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NSAIDs - inhibition of COX1 gives what side effects

inhibition of COX2…

A

inhibition of COX-1 can give associated: side effects (ulcers, prolonged bleedingtime, kidney problem)
inhibition of COX-2 accounts for the anti-inflammatory features of NSAID however side effects: (hypertension, acute kidney problems)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name some side effects of COX inhibition

A

NSAIDs are acidic & damage the GIT + irritation of gastric mucosa

COX inhibition: Prostaglandins normally have a protective role in the gastrointestinal tract (GIT) – (PGE1, PGE2 and PGI2 inhibit gastric acid secretion and prevent gastric ulcers)

COX-2 inhibitors have been found to increase the risk of thrombosis, heart attack and stroke even with short-term use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe LOX

A

Lipoxygenase (LOX)
Peroxidation of AA by 5-lipoxygenase (5-LO)
- Leukotrienes (LTA4) –> LTA4 is converted to LTB4 & cysteine leukotrienes: LTC4, LTD4, LTE4
- Hydroxyeicosatetraenoic acid (5-HETE)
- Lipoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what cells synthesize leukotrienes

what do leukotrienes signal via

A

WBCs, mast cells & platelets

Via GPCRs: principally coupled to Gαi and Gαq G proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leukotrienes in Inflammatory Diseases (7)

A
  • Asthma (Cys-LTs)
  • Atherosclerosis (LTB4 and Cys-LTs)
  • Rheumatoid arthritis (LTB4)
  • Inflammatory bowel disease (LTB4 and Cys-LTs)
  • Cancer (LTB4)
  • Inflammatory pathways in obesity (LTB4)

Other emerging roles:
- Insulin resistance (LTB4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhibitors of the LOX pathway

A

5-LO inhibitor – Zileuton is clinically used for the treatment of asthma
CysLT1 antagonists – Montelukast and Zafirlukast for asthma and seasonal allergy

17
Q

describe Alternative mechanisms to block arachidonic acid inflammation:

A

Inhibit PLA 2 –mediated AA membrane release through steroids (promote synthesis of Lipocortin  inhibits PLA 2)
Synthesis of Lipoxins (LXA4/LXB4)
Aspirin promotes the synthesis of anti-inflammatory Lipoxins